ArticleCureus2025
Intravenous Iron (III) Hydroxide Polymaltose Complex Infusion Related Severe Prolonged Hypophosphatemia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intravenous iron infusion-related hypophosphatemia is an increasingly recognized phenomenon, potentially underdiagnosed in clinical practice. This case report describes the first known instance to the best of our knowledge, of severe hypophosphatemia following iron (III) hydroxide polymaltose complex (IPC) infusion in a 60-year-old woman with multiple comorbidities. The patient, with a history of diabetes mellitus type 2, hyperlipidemia, stable stage 3 chronic kidney disease, iron deficiency anemia, and osteoporosis, was found to have severe asymptomatic hypophosphatemia (<0.1 mmol/dL) during a general workup. She exhibited mild chronic numbness of the hands and feet, restless leg syndrome, and muscular pain in her shoulders, though her clinical examination was unremarkable. The patient had received three IPC infusions over two months prior to presentation. She was admitted and treated with intravenous phosphate followed by oral sodium phosphate. The patient remained well and asymptomatic throughout the treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.